Borrelia valaisiana Resist Complement-Mediated Killing Independently of the Recruitment of Immune Regulators and Inactivation of Complement Components
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Borrelia valaisiana Resist Complement-Mediated Killing Independently of the Recruitment of Immune Regulators and Inactivation of Complement Components
Authors
Keywords
Complement system, Borrelia burgdorferi, Spirochetes, Complement activation, Immune serum, Borrelia, Lyme disease, Complement inhibitors
Journal
PLoS One
Volume 8, Issue 1, Pages e53659
Publisher
Public Library of Science (PLoS)
Online
2013-01-09
DOI
10.1371/journal.pone.0053659
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contribution of the Infection-Associated Complement Regulator-Acquiring Surface Protein 4 (ErpC) to Complement Resistance ofBorrelia burgdorferi
- (2012) Claudia Hammerschmidt et al. Clinical & Developmental Immunology
- A Metalloproteinase Karilysin Present in the Majority of Tannerella forsythia Isolates Inhibits All Pathways of the Complement System
- (2012) M. Jusko et al. JOURNAL OF IMMUNOLOGY
- Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4
- (2010) Nathalie D. van Burgel et al. BMC MICROBIOLOGY
- Inadequate Binding of Immune Regulator Factor H Is Associated with Sensitivity of Borrelia lusitaniae to Human Complement
- (2010) R. Dieterich et al. INFECTION AND IMMUNITY
- Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi
- (2010) Corinna Siegel et al. PLoS One
- Human Complement Regulators C4b-Binding Protein and C1 Esterase Inhibitor Interact with a Novel Outer Surface Protein of Borrelia recurrentis
- (2010) Sonja Grosskinsky et al. PLoS Neglected Tropical Diseases
- Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
- (2009) S. Heinen et al. BLOOD
- CspA-Mediated Binding of Human Factor H Inhibits Complement Deposition and Confers Serum Resistance in Borrelia burgdorferi
- (2009) M. R. Kenedy et al. INFECTION AND IMMUNITY
- Functional Characterization of Borrelia spielmanii Outer Surface Proteins That Interact with Distinct Members of the Human Factor H Protein Family and with Plasminogen
- (2009) A. Seling et al. INFECTION AND IMMUNITY
- Complement evasion strategies of pathogens—Acquisition of inhibitors and beyond
- (2009) Anna M. Blom et al. MOLECULAR IMMUNOLOGY
- Binding of the complement inhibitor C4b-binding protein to Lyme disease borreliae
- (2009) Johanna Pietikäinen et al. MOLECULAR IMMUNOLOGY
- Borrelia recurrentis Employs a Novel Multifunctional Surface Protein with Anti-Complement, Anti-Opsonic and Invasive Potential to Escape Innate Immunity
- (2009) Sonja Grosskinsky et al. PLoS One
- Identification and characterization of the factor H and FHL-1 binding complement regulator-acquiring surface protein 1 of the Lyme disease spirochete Borrelia spielmanii sp. nov.
- (2008) P HERZBERGER et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Deciphering the Ligand-binding Sites in theBorrelia burgdorferiComplement Regulator-acquiring Surface Protein 2 Required for Interactions with the Human Immune Regulators Factor H and Factor H-like Protein 1
- (2008) Corinna Siegel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Complement evasion by human pathogens
- (2008) John D. Lambris et al. NATURE REVIEWS MICROBIOLOGY
- Factor H family proteins and human diseases
- (2008) Mihály Józsi et al. TRENDS IN IMMUNOLOGY
- C1, MBL–MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation
- (2008) László Beinrohr et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation